F. Javier González-Rico
Jiyue Zhu
Guangyong Peng- 1Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias, Universidad de Extremadura, Badajoz, Spain
- 2Department of Pharmaceutical Sciences, Washington State University, Spokane, WA, United States
- 3Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, Saint Louis, MO, United States
Editorial on the Research Topic
Senescence and reprogramming: hallmarks in aging and disease
Aging is a biological process marked by the gradual decline of molecular, cellular and tissue functionality. This progressive degeneration is intrisically linked to advancing age and contributing to the development of age-related diseases, such as cancer, cardiovascular diseases, neurodegenerative conditions, osteoporosis, kidney and lung failure, among others.
The twelve hallmarks driving the aging process are genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis (López-Otín et al., 2023). These hallmarks share three defining characteristics: they manifest during physiological aging, their experimental exacerbation accelerates aging, and their mitigation through intervention slows aging, thereby extending healthy lifespan (Tartiere et al., 2024).
The aging-associated characteristics are closely linked to cellular senescence, a state defined by cell cycle arrest, spatial chromatin reorganization, and alterations in gene expression patterns. These changes also lead to the secretion of proinflammatory cytokines, proteases and growing factors, collectively known as Senescence-Associated Secretory Phenotype (SASP) (Campisi and d’Adda di Fagagna, 2007). A key driver of replicative cellular senesence is the progressive shortening of telomeres that occurs with aging. Additionally, cells can enter senescence in response to various stressors, including sustained mitogenic signaling, oncogene activation, DNA damage from irradiation, oxidative and genotoxic stress, epigenetic alterations, chromatin disorganization, perturbed proteostasis, mitochondrial dysfunction, inflammation signals, tissue damage, chemotherapeutic agents, and nutrient deprivation (Kumari and Jat, 2021).
Both cellular senescence and organismal aging are closely connected to epigenetic states. During development, epigenetic modifications, including DNA methylation, histone modifications, and chromatin remodeling, collectively determine cellular differentiation status and cell fates. These differentiation states can also be reversed through the transcriptional and/or epigentic reprogramming of the cell. In cell reprogramming, the cell identity and plasticity can be altered by the overexpression of transcription factors such as Oct4, Sox2, Klf4 and c-Myc (OSKM) (Takahashi and Yamanaka, 2006). This induction creates a dedifferentiation state that enhances tissue regeneration and has been succesfully applied in various pathological contexts, including diabetes, muscle injuries, retinal degeneration, and myocardial infarction (Ocampo et al., 2016; Lu et al., 2020; Chen et al., 2021). Those studies reveal the potential of cell reprogramming tools for controlling cell fate and function for disease therapies.
Within this broad context, we present an article Research Topic for Frontiers under the Research Topic “Senescence and Reprogramming: Hallmarks in Aging and Disease”, offering expert and up to date perspective on aging, senescence and reprogramming, encompassing both original research and review articles.
In this Research Topic, Cai et al. present an original research investigating the application of electromagnetic fields (EMF) to rejuvenate aged bone marrow mesenchymal stem cells (BMSCs). They established a robust experimental model in the field of tissue engineering, demonstrating potential for stem cell therapy. Their detailed methodological description, complemented by rigorous controls, provides a valuable tool for research groups studying stem cell aging.
Chen et al. elucidate the role of Vitamin D in regulating granulosa cell aging and homone balance. Using the Vitamin D receptor (VDR) deficiency mice, they showed the importance of VDR in follicle maturation and hormone secretion, identifying its deficiency as a driver of premature ovarian insufficiency. Their study further demonstrates that Vdr deficiency accelerates granulosa cell aging through the antioxidant and anti-aging effect of 7-dehydrocholesterol (7-DHC). Employing both human and murine models, they apply a comprehensive methodological approach, including genome editing for knockout generation, chromatin immunoprecipitation, and intracelular ROS analysis via flow cytometry.
Keshri et al. contribute a review article discussing emerging strategies in direct reprogramming, addressing challenges related to efficacy, cellular maturity, and targeting specificity. Their work covers multiple aspects of transdifferentiation, including signalling pathways, epigenetic modifications, and metabolic regulation. They also discussed next-generation tools in reprogramming, such as minibinders, EpiBinders, CRISPR-Cas9, and chromatin modulation by pioneer transcription factors.
In a complementary perspective, Moledo-Nodar et al. examine progeroid syndomes, emphasizing the therapeutic promise of partial reprogramming strategies that erase age-associated cellular characteristics while preserving identity. Given the phenotypic overlap between progeroid syndromes and physiological aging, their discussion underscores both the potential and the challenges inherent in applying reprogramming-based therapies to these rare genetic disorders.
Finally, Sinenko et al. reviewed the molecular mechanisms governed by and influencing metabolic pathways during the reprogramming process. Their comprehensive analysis discussed the stages of cell reprogramming toward pluripotency in both human and mouse induced pluripotent stem cells (iPSCs), with a particular focus on metabolic profiles and the transcription factors and pathways involved.
We hope that the articles featured in this Research Topic will serve as valuable resources for researchers in the fields of aging, senescence, and cell reprogramming, whether they are well-established experts or newcomers eager to explore this exciting arena.
Author contributions
FG-R: Writing – original draft, Writing – review and editing. JZ: Writing – review and editing. GP: Writing – review and editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. JZ is supported by NIH grants: R01AG073423, R35GM149529; Department of Defense CDMRP/Melanoma Research Program ME220261. FG-R was supported by the program Ayudas a Talento AECC (Asociación Española Contra el Cáncer). GP is supported by the NIH (CA184379, CA242188, CA237149, AI 173260, AG078822, and AG067441 to GP).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The authors declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Campisi, J., and d’Adda di Fagagna, F. (2007). Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8 (9), 729–740. doi:10.1038/nrm2233
Chen, Y., Lüttmann, F. F., Schoger, E., Schöler, H. R., Zelarayán, L. C., Kim, K. P., et al. (2021). Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. Sci. (New York, N.Y.) 373 (6562), 1537–1540. doi:10.1126/science.abg5159
Kumari, R., and Jat, P. (2021). Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory Phenotype. Front. Cell Dev. Biol. 9, 645593. doi:10.3389/fcell.2021.645593
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2023). Hallmarks of aging: an expanding universe. Cell 186 (2), 243–278. doi:10.1016/j.cell.2022.11.001
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., et al. (2020). Reprogramming to recover youthful epigenetic information and restore vision. Nature 588 (7836), 124–129. doi:10.1038/s41586-020-2975-4
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., et al. (2016). In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167 (7), 1719–1733.e12. doi:10.1016/j.cell.2016.11.052
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (4), 663–676. doi:10.1016/j.cell.2006.07.024
Keywords: reprogramming, aging, senescence, OSKM, cancer, transdifferentiation, progeroid syndromes
Citation: González-Rico FJ, Zhu J and Peng G (2025) Editorial: Senescence and reprogramming: hallmarks in aging and disease. Front. Cell Dev. Biol. 13:1622682. doi: 10.3389/fcell.2025.1622682
Received: 04 May 2025; Accepted: 05 May 2025;
Published: 16 May 2025.
Edited and reviewed by:
Atsushi Asakura, University of Minnesota Twin Cities, United StatesCopyright © 2025 González-Rico, Zhu and Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: F. Javier González-Rico, Zmpnb256YWxlekB1bmV4LmVz